Researchers have found in a new study that adding two percent crisaborole ointment to amorolfine hydrochloride cream significantly enhances therapeutic outcomes in the management of ...
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Verona ...
Abstract: Unknown distributed incipient thermal fault detection and localization are vital to the safe operation of batteries while they have not been given sufficient attention in existing works ...
Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical ...
In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Arcutis Biotherapeutics, Inc. stands ninth among them. Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is ...
In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. On July 8, Jared Holz of Mizuho spoke on CNBC’s “Closing Bell Overtime” about whether the biotech ...
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is one of the 14 Best Small Cap Stocks to Buy Right Now. On September 3, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) submitted a supplemental New Drug ...
Center for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, DK-2100 Copenhagen, Denmark ...
Background: The cornerstone medications for maintenance of chronic obstructive pulmonary disease (COPD) have remained the same for decades. Despite combination therapy with multiple mechanisms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback